Authors
Abdeljalil Elmahdaoui, Manal Zefzoufi, Lansine Diakité, Mohammed Haida, Rabiaa Fdil, Aziz Auhmani, Stefania Garzoli, Zahra Sokar
Published in
Chemistry & biodiversity. Volume 23. Issue 10. Pages e71802.
Abstract
Mercurialis annua L. (Euphorbiaceae) is traditionally used to treat renal disorders, although its nephroprotective activity remains poorly documented. This study characterized the phytochemical profile of the Moroccan hydroethanolic extract by UHPLC-ESI/MS, evaluated its acute toxicity, and investigated its protective effect against cyclophosphamide-induced nephrotoxicity in rats. UHPLC-ESI/MS tentatively identified phenolic and flavonoid constituents, including isorhamnetin derivatives, taxifolin, epicatechin, and hydro-p-coumaric acid hexoside. No mortality or treatment-related toxicity was observed up to 5000 mg/kg. Oral administration of the extract (200 and 400 mg/kg) significantly reduced serum creatinine, blood urea nitrogen, kidney weight, and malondialdehyde levels while restoring superoxide dismutase and peroxidase activities. Histopathological examination confirmed marked attenuation of renal damage, particularly at 400 mg/kg. These findings provide the first phytochemical characterization of Moroccan M. annua and support its potential as a safe natural nephroprotective agent through antioxidant-related mechanisms.
PMID:
42816175
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0